Elaine Sorg
Vermögen: - $ am 30.06.2026
Vermögen: - $ am 30.06.2026
Elaine K.
Sorg is Director at Artiva Biotherapeutics, Inc. since 2026.
Ms. Sorg is Independent Non-Executive Director at CSL Ltd. since 2024.
Ms. Sorg was Senior VP & President-US Commercial Operations at AbbVie, Inc. from 2020 to 2024.
Ms. Sorg completed graduate studies at Harvard Business School and the University of Chicago Booth School of Business.
Ms. Sorg completed undergraduate studies at Purdue University.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 31.03.2026 | 0 ( -.--% ) | - $ | 30.06.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| CSL LIMITED | Direktor/Vorstandsmitglied | 01.09.2024 |
| ARTIVA BIOTHERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 19.02.2026 |
| Unternehmen | Position | Ende |
|---|---|---|
| ABBVIE INC. | Corporate Officer/Principal | 01.01.2024 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 5 |
|---|---|
CSL Ltd.
CSL Ltd. BiotechnologyHealth Technology Develops and manufactures medicines that treat people with rare and serious diseases | Health Technology |
AbbVie, Inc.
AbbVie, Inc. Pharmaceuticals: MajorHealth Technology Engages in the research and development, manufacturing, commercialization & sale of immunology medicines and therapies | Health Technology |
Purdue University
Purdue University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard Business School
Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Artiva Biotherapeutics, Inc.
Artiva Biotherapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops natural killer cell-based therapies for patients suffering from autoimmune diseases and cancers | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen